To demonstrate the proof of principle for the targeting of the PRMT1/PRMT6 heteromer in lung cancer, we showed that disrupting the complex reduced cell viability in LC PDOs from a Caucasian male (PDXO) and a Black/AA female (PDO). Here, PRMT1 is linked to lung carcinoma.